Kimiko Suzuki is a PhD student in the Curriculum for Bioinformatics and Computational Biology. She works in both the Dohlman and Elston labs located in the Department of Pharmacology at the UNC School of Medicine. Her research focuses on predicting how intracellular signaling pathways respond to stress.
A new technique uses stem cells to deliver anti-cancer drugs to aggressive brain tumors that are, otherwise, often inaccessible. This potentially life-saving treatment was developed by UNC pharmacoengineer Shawn Hingtgen.
With new funding, a UNC startup is poised to halt the most devastating effects of chemotherapy.
UNC researchers have discovered a new target for chronic pain treatment.
Two UNC researchers design a biological test to individualize chemotherapy.
UNC’s Patrick Giguere uncovers a single sodium ion that regulates how pain medications work in the brain, a key discovery that carries the promise of a better class of drugs.